XBI holdings

All 166 positions of State Street SPDR S&P Biotech ETF.

Download CSV

Positions

166

Top 10 weight

16.9%

Effective holdings

92.6

1 / sum of squared weights

In stocks

99.9%

In bonds

0.0%

Outside the US

0.0%

Asset mix

Equity99.9%
Other0.1%
Cash0.0%

Sectors

100% of stocks classified

Health Care99.2%
Financials0.7%

Countries

United States96.3%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	MRNAModerna, Inc. Common Stock	Equity	2.20%	—	1,119,330	US
2	TWSTTwist Bioscience Corporation Common Stock	Equity	1.84%	—	1,209,302	US
3	NTRANatera, Inc. Common Stock	Equity	1.79%	—	459,561	US
4	ABBVABBVIE INC.	Equity	1.65%	—	605,006	US
5	UTHRUnited Therapeutics Corp	Equity	1.59%	—	299,526	US
6	AMGNAmgen Inc	Equity	1.58%	—	387,970	US
7	BIIBBiogen Inc. Common Stock	Equity	1.57%	—	720,304	US
8	HALOHalozyme Therapeutics, Inc.	Equity	1.55%	—	1,413,416	US
9	IOVAIovance Biotherapeutics, Inc. Common Stock	Equity	1.54%	—	11,557,174	US
10	EXELExelixis Inc	Equity	1.53%	—	2,602,250	US
11	GILDGilead Sciences Inc	Equity	1.53%	—	1,042,189	US
12	TGTXTG Therapeutics, Inc.	Equity	1.48%	—	2,777,508	US
13	VRTXVertex Pharmaceuticals Inc	Equity	1.46%	—	291,305	US
14	PTGXProtagonist Therapeutics, Inc	Equity	1.46%	—	1,041,100	US
15	KRYSKrystal Biotech, Inc. Common Stock	Equity	1.43%	—	436,094	US
16	CRSPCRISPR Therapeutics AG	Equity	1.41%	—	2,790,326	US
17	PTCTPTC Therapeutics, Inc.	Equity	1.40%	—	2,246,451	US
18	SYRESpyre Therapeutics, Inc. Common Stock	Equity	1.39%	—	1,746,067	US
19	REGNRegeneron Pharmaceuticals Inc	Equity	1.39%	—	187,934	US
20	NBIXNeurocrine Biosciences Inc	Equity	1.38%	—	978,400	US
21	RVMDRevolution Medicines, Inc. Common Stock	Equity	1.37%	—	730,955	US
22	INCYIncyte Genomics Inc	Equity	1.36%	—	1,204,542	US
23	ALKSAlkermes Inc. plc	Equity	1.34%	—	3,343,401
24	GRALGRAIL, Inc. Common Stock	Equity	1.33%	—	1,006,118	US
25	ERASErasca, Inc. Common Stock	Equity	1.33%	—	8,609,322	US
26	PCVXVaxcyte, Inc. Common Stock	Equity	1.33%	—	2,044,538	US
27	MDGLMadrigal Pharmaceuticals, Inc. Common Stock	Equity	1.32%	—	277,672	US
28	ALNYAlnylam Pharmaceuticals, Inc.	Equity	1.32%	—	588,313	US
29	BBIOBridgeBio Pharma, Inc. Common Stock	Equity	1.30%	—	1,995,153	US
30	BMRNBioMarin Pharmaceuticals Inc	Equity	1.29%	—	2,356,591	US
31	ORKAOruka Therapeutics, Inc. Common Stock	Equity	1.28%	—	1,658,906	US
32	CYTKCytokinetics Inc.	Equity	1.27%	—	2,048,252	US
33	ROIVRoivant Sciences Ltd. Common Shares	Equity	1.24%	—	3,630,551
34	KODKodiak Sciences Inc Common Stock	Equity	1.24%	—	1,316,921	US
35	COGTCogent Biosciences, Inc. Common Stock	Equity	1.20%	—	4,007,083	US
36	KYMRKymera Therapeutics, Inc. Common Stock	Equity	1.20%	—	1,099,219	US
37	TVTXTravere Therapeutics, Inc. Common Stock	Equity	1.19%	—	2,292,214	US
38	IBRXImmunityBio, Inc. Common Stock	Equity	1.19%	—	12,020,746	US
39	INSMInsmed, Inc.	Equity	1.18%	—	1,178,511	US
40	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	1.17%	—	2,709,662	US
41	DNTHDianthus Therapeutics, Inc. Common Stock	Equity	1.17%	—	1,418,082	US
42	PRAXPraxis Precision Medicines, Inc. Common Stock	Equity	1.16%	—	439,593	US
43	ARWRArrowhead Research Corporation	Equity	1.11%	—	1,837,031	US
44	RYTMRhythm Pharmaceuticals, Inc. Common Stock	Equity	1.09%	—	1,216,593	US
45	VCYTVeracyte, Inc.	Equity	1.04%	—	2,395,555	US
46	MIRMMirum Pharmaceuticals, Inc. Common Stock	Equity	1.03%	—	1,262,470	US
47	CGONCG Oncology, Inc. Common stock	Equity	1.00%	—	1,583,635	US
48	VKTXViking Therapeutics, Inc	Equity	0.98%	—	3,538,660	US
49	TNGXTango Therapeutics, Inc.	Equity	0.94%	—	4,175,923	US
50	RLAYRelay Therapeutics, Inc. Common Stock	Equity	0.87%	—	4,995,509	US
51	BEAMBeam Therapeutics Inc. Common Stock	Equity	0.87%	—	3,535,069	US
52	CDNACareDx, Inc.	Equity	0.84%	—	1,357,309	US
53	CELCCelcuity Inc. Common Stock	Equity	0.83%	—	1,229,758	US
54	RAREUltragenyx Pharmaceutical Inc.	Equity	0.80%	—	5,235,072	US
55	SRRKScholar Rock Holding Corporation Common Stock	Equity	0.79%	—	1,872,897	US
56	ARQTArcutis Biotherapeutics, Inc. Common Stock	Equity	0.76%	—	3,102,705	US
57	DYNDyne Therapeutics, Inc. Common Stock	Equity	0.73%	—	4,468,487	US
58	PURRHyperliquid Strategies Inc Common Stock	Equity	0.70%	—	6,155,850	US
59	RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	Equity	0.67%	—	17,064,397	US
60	SLSSELLAS Life Sciences Group, Inc. Common Stock	Equity	0.65%	—	5,820,692	US
61	IMVTImmunovant, Inc. Common Stock	Equity	0.65%	—	2,164,744	US
62	SMMTSummit Therapeutics Inc. Common Stock	Equity	0.64%	—	3,734,403	US
63	IDYAIDEAYA Biosciences, Inc. Common Stock	Equity	0.59%	—	1,629,912	US
64	BCRXBioCryst Pharmaceuticals Inc	Equity	0.59%	—	7,079,223	US
65	DNLIDenali Therapeutics Inc. Common Stock	Equity	0.59%	—	3,138,756	US
66	VERAVera Therapeutics, Inc. Class A Common Stock	Equity	0.56%	—	1,884,523	US
67	AGIOAgios Pharmaceuticals, Inc.	Equity	0.56%	—	1,750,069	US
68	NTLAIntellia Therapeutics, Inc	Equity	0.55%	—	4,403,402	US
69	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	0.55%	—	3,040,576	US
70	NVAXNovavax Inc	Equity	0.52%	—	4,729,369	US
71	RCUSArcus Biosciences, Inc.	Equity	0.51%	—	2,127,537	US
72	NRIXNurix Therapeutics, Inc. Common stock	Equity	0.50%	—	2,252,432	US
73	ACADAcadia Pharmaceuticals Inc.	Equity	0.50%	—	2,540,023	US
74	PVLAPalvella Therapeutics, Inc. Common Stock	Equity	0.49%	—	372,183	US
75	CLDXCelldex Therapeutics, Inc	Equity	0.48%	—	1,646,945	US
76	ADMAADMA Biologics, Inc.	Equity	0.48%	—	4,657,955	US
77	QUREuniQure N.V.	Equity	0.47%	—	2,086,998
78	VRDNViridian Therapeutics, Inc. Common Stock	Equity	0.47%	—	2,563,621	US
79	ABSIAbsci Corporation Common Stock	Equity	0.45%	—	5,081,515	US
80	VCELVericel Corporation	Equity	0.45%	—	1,133,599	US
81	BHVNBiohaven Ltd.	Equity	0.45%	—	3,800,345
82	IRONDisc Medicine, Inc. Common Stock	Equity	0.45%	—	739,422	US
83	PGENPrecigen, Inc. Common Stock	Equity	0.44%	—	5,828,914	US
84	SNDXSyndax Pharmaceuticals, Inc.	Equity	0.44%	—	2,616,846	US
85	NKTRNektar Therapeutics	Equity	0.41%	—	1,001,849	US
86	IMNMImmunome, Inc.	Equity	0.39%	—	2,004,547	US
87	MLYSMineralys Therapeutics, Inc. Common Stock	Equity	0.34%	—	1,508,804	US
88	REPLReplimune Group, Inc.	Equity	0.33%	—	2,555,905	US
89	XNCRXencor, Inc.	Equity	0.33%	—	1,339,548	US
90	STOKStoke Therapeutics, Inc. Common Stock	Equity	0.32%	—	1,347,422	US
91	INBXInhibrx Biosciences, Inc. Common Stock	Equity	0.31%	—	333,669	US
92	ANABAnaptysBio, Inc. Common Stock	Equity	0.30%	—	657,829	US
93	ORICOric Pharmaceuticals, Inc. Common Stock	Equity	0.30%	—	2,483,651	US
94	VIRVir Biotechnology, Inc. Common Stock	Equity	0.29%	—	2,615,670	US
95	TRAXFirst Tracks Biotherapeutics, Inc. Ordinary Shares	Equity	0.29%	—	898,024	US
96	ZBIOZenas BioPharma, Inc. Common Stock	Equity	0.28%	—	1,065,994	US
97	KURAKura Oncology, Inc.	Equity	0.27%	—	2,610,822	US
98	MNKDMannkind Corporation	Equity	0.25%	—	7,361,661	US
99	JBIOJade Biosciences, Inc. Common Stock	Equity	0.25%	—	1,761,500	US
100	ARDXArdelyx, Inc.	Equity	0.24%	—	7,471,288	US
101	ANNXAnnexon, Inc. Common Stock	Equity	0.24%	—	6,007,321	US
102	RIGLRigel Pharmaceuticals Inc. (New)	Equity	0.24%	—	486,725	US
103	TYRATyra Biosciences, Inc. Common Stock	Equity	0.24%	—	1,186,379	US
104	TSHATaysha Gene Therapies, Inc. Common Stock	Equity	0.23%	—	5,279,170	US
105	GERNGeron Corp	Equity	0.23%	—	18,548,930	US
106	GLUEMonte Rosa Therapeutics, Inc. Common Stock	Equity	0.22%	—	2,163,017	US
107	CADLCandel Therapeutics, Inc. Common Stock	Equity	0.22%	—	2,239,097	US
108	JANXJanux Therapeutics, Inc. Common Stock	Equity	0.22%	—	1,165,349	US
109	VORVor Biopharma Inc. Common Stock	Equity	0.21%	—	1,121,446	US
110	AVTXAvalo Therapeutics, Inc. Common Stock	Equity	0.20%	—	1,510,761	US
111	IMMXImmix Biopharma, Inc. Common Stock	Equity	0.20%	—	2,113,641	US
112	CGEMCullinan Therapeutics, Inc. Common Stock	Equity	0.19%	—	1,259,806	US
113	BCAXBicara Therapeutics Inc. Common Stock	Equity	0.19%	—	1,122,007	US
114	CRVSCorvus Pharmaceuticals, Inc.	Equity	0.19%	—	1,861,104	US
115	VSTMVerastem, Inc.	Equity	0.19%	—	2,308,557	US
116	OLMAOlema Pharmaceuticals, Inc. Common Stock	Equity	0.17%	—	2,203,691	US
117	RGNXREGENXBIO Inc.	Equity	0.16%	—	2,035,249	US
118	COAGHemab Therapeutics Holdings, Inc. Common Stock	Equity	0.16%	—	528,916	US
119	SVRASavara Inc.	Equity	0.16%	—	3,270,519	US
120	AVBPArriVent BioPharma, Inc. Common Stock	Equity	0.16%	—	943,681	US
121	SANASana Biotechnology, Inc. Common Stock	Equity	0.16%	—	5,611,167	US
122	ACHVAchieve Life Sciences, Inc.	Equity	0.15%	—	2,152,834	US
123	FDMT4D Molecular Therapeutics, Inc. Common Stock	Equity	0.15%	—	1,206,956	US
124	DMRADamora Therapeutics, Inc. Ordinary Shares	Equity	0.15%	—	743,457	US
125	CAPRCapricor Therapeutics Inc	Equity	0.15%	—	1,828,162	US
126	ALLOAllogene Therapeutics, Inc. Common Stock	Equity	0.13%	—	9,510,630	US
127	PRMEPrime Medicine, Inc. Common Stock	Equity	0.13%	—	3,716,932	US
128	IRWDIronwood Pharmaceuticals, Inc. - Class A	Equity	0.13%	—	3,411,549	US
129	CTMXCytomX Therapeutics, Inc.	Equity	0.13%	—	5,215,402	US
130	KLRAKailera Therapeutics, Inc. Common Stock	Equity	0.13%	—	1,255,239	US
131	EDITEditas Medicine, Inc. Common Stock	Equity	0.12%	—	4,344,930	US
132	SLDBSolid Biosciences Inc. Common Stock	Equity	0.12%	—	1,797,751	US
133	MYGNMyriad Genetics Inc	Equity	0.12%	—	2,910,110	US
134	CLYMClimb Bio, Inc. Common Stock	Equity	0.12%	—	1,105,587	US
135	ABUSArbutus Biopharma Corporation Common Stock	Equity	0.12%	—	2,869,130
136	ALTAltimmune, Inc. Common Stock	Equity	0.12%	—	4,572,105	US
137	MNPRMonopar Therapeutics Inc. Common Stock	Equity	0.12%	—	141,026	US
138	SGMTSagimet Biosciences Inc. Series A Common Stock	Equity	0.12%	—	1,297,732	US
139	EBSEmergent Biosolutions, Inc.	Equity	0.11%	—	1,659,748	US
140	DSGNDesign Therapeutics, Inc. Common Stock	Equity	0.11%	—	960,119	US
141	OCGNOcugen, Inc. Common Stock	Equity	0.11%	—	11,125,705	US
142	STTKShattuck Labs, Inc. Common Stock	Equity	0.11%	—	1,882,408	US
143	SPRYARS Pharmaceuticals, Inc. Common Stock	Equity	0.10%	—	2,235,167	US
144	CABACabaletta Bio, Inc. Common Stock	Equity	0.10%	—	5,079,179	US
145	AKTSAktis Oncology, Inc. Common stock	Equity	0.09%	—	523,832	US
146	MDXGMiMedx Group, Inc	Equity	0.09%	—	1,848,590	US
147	VNDAVanda Pharmaceuticals Inc.	Equity	0.08%	—	1,837,598	US
148	PRTAProthena Corporation plc Ordinary Shares	Equity	0.08%	—	928,875
149	CONTRA METSERA INC	Other	0.07%	—	1,530,714	US
150	NGNENeurogene, Inc. Common Stock	Equity	0.07%	—	274,325	US
151	ASMBAssembly Biosciences, Inc	Equity	0.07%	—	309,972	US
152	OVIDOvid Therapeutics Inc. Common Stock	Equity	0.07%	—	2,851,399	US
153	AURAAura Biosciences, Inc. Common Stock	Equity	0.06%	—	963,761	US
154	FTHFaeth Therapeutics, Inc. Common Stock	Equity	0.06%	—	220,244	US
155	LXEOLexeo Therapeutics, Inc. Common Stock	Equity	0.05%	—	1,625,226	US
156	CMPXCompass Therapeutics, Inc. Common Stock	Equity	0.05%	—	4,939,320	US
157	CBIOCrescent Biopharma, Inc. Common Stock	Equity	0.05%	—	341,576	US
158	SSI US GOV MONEY MARKET CLASS	Cash	0.05%	—	4,639,423
159	BBOTBridgeBio Oncology Therapeutics, Inc. Common Stock	Equity	0.02%	—	676,447	US
160	CONTRA AKERO THERAPEUT	Other	0.01%	—	2,033,975	US
161	CONTRA INHIBRX INC	Other	0.01%	—	1,645,973	US
162	CONTRA MIRATI THERAPEU	Other	0.01%	—	1,369,552	US
163	CONTRA VERVE THERAPEUT	Other	0.01%	—	900,273	US
164	CONTRA BLUEPRINT MEDIC	Other	0.00%	—	756,469
165	OMNIAB INC 12.5 EARNOUT	Other	0.00%	—	161,959
166	OMNIAB INC 15.00 EARNOUT	Other	0.00%	—	161,959

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Exit	APLSApellis Pharmaceuticals Inc	1.83%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	FOLDAmicus Therapeutics Inc	1.15%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	ACLXArcellx Inc	1.14%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SLSSELLAS Life Sciences Group Inc	0.27%	1.19%	+51.3%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ORKAOruka Therapeutics Inc	0.50%	1.38%	+67.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	RLAYRelay Therapeutics Inc	0.38%	1.10%	+82.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	SLNOSoleno Therapeutics Inc	0.67%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	uniQure NV	0.37%	1.03%	+15.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DNTHDianthus Therapeutics Inc	0.66%	1.18%	+82.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	MRNAModerna Inc	1.03%	1.41%	+17.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ARQTArcutis Biotherapeutics Inc	1.09%	0.71%	−30.5%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	AVTXAvalo Therapeutics Inc	—	0.35%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	Alkermes PLC	1.45%	1.11%	−39.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	MDGLMadrigal Pharmaceuticals Inc	1.38%	1.06%	−11.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	DAWNDay One Biopharmaceuticals Inc	0.32%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	JBIOJade Biosciences Inc	—	0.32%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	PURRHyperliquid Strategies Inc	0.17%	0.46%	+111.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	KALVKalVista Pharmaceuticals Inc	0.29%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	TNGXTango Therapeutics Inc	0.56%	0.84%	+20.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	IMNMImmunome Inc	0.86%	0.59%	−16.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	VKTXViking Therapeutics Inc	1.04%	1.30%	+24.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ARDXArdelyx Inc	0.62%	0.35%	−20.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	INSMInsmed Inc	1.34%	1.08%	+46.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	NTLAIntellia Therapeutics Inc	0.65%	0.91%	+25.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	TGTXTG Therapeutics Inc	1.35%	1.09%	−42.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	TWSTTwist Bioscience Corp	1.16%	1.41%	−33.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	ERASErasca Inc	1.03%	1.27%	+29.0%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	SLDBSolid Biosciences Inc	—	0.24%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	NUVLNuvalent Inc	1.17%	0.93%	−21.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SMMTSummit Therapeutics Inc	1.24%	1.01%	+25.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	IRONDisc Medicine Inc	0.87%	0.65%	−22.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	EXELExelixis Inc	1.17%	0.96%	−23.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	APGEApogee Therapeutics Inc	1.28%	1.49%	−13.0%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	IMMXImmix Biopharma Inc	—	0.20%	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	CADLCandel Therapeutics Inc	—	0.19%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	NBIXNeurocrine Biosciences Inc	1.16%	0.97%	−22.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	AGIOAgios Pharmaceuticals Inc	0.88%	0.69%	−14.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GRALGRAIL Inc	0.72%	0.91%	+12.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CLDXCelldex Therapeutics Inc	0.52%	0.70%	+35.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	IOVAIovance Biotherapeutics Inc	0.38%	0.56%	+46.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	REGNRegeneron Pharmaceuticals Inc	1.14%	0.96%	+24.0%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	TRAXFirst Tracks Biotherapeutics Inc	—	0.17%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	PTGXProtagonist Therapeutics Inc	1.24%	1.07%	−12.1%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	MPLTMapLight Therapeutics Inc	—	0.17%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	VIRVir Biotechnology Inc	0.30%	0.47%	+60.4%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	ARWRArrowhead Pharmaceuticals Inc	1.23%	1.07%	−20.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CGEMCullinan Therapeutics Inc	0.25%	0.40%	+49.1%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	CABACabaletta Bio Inc	—	0.15%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	PTCTPTC Therapeutics Inc	1.18%	1.03%	−13.7%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	NVAXNovavax Inc	0.51%	0.66%	+32.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	SRPTSarepta Therapeutics Inc	0.89%	0.75%	+19.6%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	DMRADamora Therapeutics Inc	0.03%	0.17%	+524.9%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	INCYIncyte Corp	1.13%	1.00%	−13.5%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	RCKTRocket Pharmaceuticals Inc	0.13%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC
New position	OVIDOvid therapeutics Inc	—	0.12%	—	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	GILDGilead Sciences Inc	1.09%	0.96%	+15.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	CMPXCompass Therapeutics Inc	0.26%	0.14%	+52.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	PVLAPalvella Therapeutics Inc	0.46%	0.58%	+22.2%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	BCAXBicara Therapeutics Inc	0.19%	0.30%	+28.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Exit	AKBAAkebia Therapeutics Inc	0.11%	—	—	Mar 31, 2026 → Jun 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.